The upregulation of FSIP1 (fibrous sheath interacting protein 1) correlates with poor prognosis in breast cancer and FSIP1 knockout in a mouse model has been found to improve docetaxel sensitivity [85]. This evidence concerns the gene FSIP1 and breast carcinoma.